BeOne Medicines (ONC) Earnings Date, Estimates & Call Transcripts $276.42 +6.72 (+2.49%) As of 09:42 AM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BeOne Medicines Earnings Summary BeOne Medicines announced Q1 2025 earnings on May 7, 2025, reporting an EPS of $1.22, which topped the consensus estimate of -$0.71 by $1.93. Quarterly revenue was reported to be $1.12 billion, below analysts' expectations of $1.12 billion. With a trailing EPS of -$3.72, BeOne Medicines' earnings are expected to grow next year, from ($5.82) to $0.71 per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConsensus EPS (May. 7) -$0.71 Actual EPS (May. 7) $1.22 Beat By $1.93 Actual Revenue (May. 7) $1.12B Get BeOne Medicines Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BeOne Medicines and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataONC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ONC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. BeOne Medicines Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251-$0.61-$0.61-$0.61Q2 20251-$0.08-$0.08-$0.08Q3 20251-$0.05-$0.05-$0.05Q4 20251-$0.04-$0.04-$0.04 BeOne Medicines Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025-$0.71$1.22+$1.93$0.01$1.12B$1.12B2/27/2025Q4 2024-$0.88-$1.43 -$0.55-$1.43$1.09B$1.13B BeOne Medicines Earnings - Frequently Asked Questions When did BeOne Medicines announce their last quarterly earnings? BeOne Medicines (NASDAQ:ONC) last announced its quarterly earning data on Wednesday, May 7, 2025. Learn more on ONC's earnings history. What guidance has BeOne Medicines issued on next quarter's earnings? BeOne Medicines updated its FY 2025 earnings guidance on Wednesday, May, 7th. The company issued revenue guidance of $4.9 billion-$5.3 billion, compared to the consensus revenue estimate of $5.1 billion. Did BeOne Medicines beat their earnings estimates last quarter? In the previous quarter, BeOne Medicines (NASDAQ:ONC) reported $1.22 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.71) by $1.93. Learn more on analysts' earnings estimate vs. ONC's actual earnings. How much revenue does BeOne Medicines generate each year? BeOne Medicines (NASDAQ:ONC) has a recorded annual revenue of $3.81 billion. How much profit does BeOne Medicines generate each year? BeOne Medicines (NASDAQ:ONC) has a recorded net income of -$644.79 million. ONC has generated -$3.72 earnings per share over the last four quarters. What is BeOne Medicines' EPS forecast for next year? BeOne Medicines' earnings are expected to grow from ($5.82) per share to $0.71 per share in the next year. More Earnings Resources from MarketBeat Related Companies GSK Earnings TAK Earnings ARGX Earnings BNTX Earnings SMMT Earnings TEVA Earnings INSM Earnings ITCI Earnings GMAB Earnings MRNA Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still Strong This page (NASDAQ:ONC) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeOne Medicines Ltd. - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BeOne Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
